This week we start a three part series on early detection- blood based, AI and EHR based, multiple cancers with one test. As the vision comes true, it promises to prevent so many early deaths. This week we talk to Nick Papadapolous from Johns Hopkins Kimmel Cancer Center
When exercise is the prescription!
Our new podcast on a truly remarkable study in patient getting chemotherapy for colorectal cancer. More than just an improvement in outcome- it gives patients agency in their care.
podcasts.apple.com/us/podcast/t...
Link to the Davey Awards, where we won a Gold Medal -Podcast Series: Health & Wellness
daveyawards.com/winners-area...
The Good News About Cancer is now a ‘Gold Medal Award Winner’ !
Here is season 2 episode 1 with Andrea Cercek from @mskcc.bsky.social
podcasts.apple.com/us/podcast/t...
What could be better #GoodNewsAboutCancer than showing that healthy pregnancies with no cancer risk are possible during rx for #BreastCancer? #AnnePartridge discussed the "Positive" Study from Dana-Farber Cancer Institute on this weeks episode!
podcasts.apple.com/us/podcast/t...
1/3 Big congrats to Justin Hwang, Emmanuel Antonarakis, @charlesryanmd.bsky.social & team on a story looking at germline HSD3B1 (which is linked to prostate cancer mortality) vs. tumor findings in prostate cancer! A couple of things that I find interesting here!🧪 www.mdpi.com/2072-6694/17...
From 2010 to 2016 (latest data I have ), NIH research contributed to EVERY drug approved by the FDA
Just a reminder that when you give (or take) abiraterone for prostate cancer, you get a bunch of complex steroidal metabolites with various activities. It is messy. Below is what occurs after a single dose. 🧪
www.jci.org/articles/vie...
This week we talk to Pam Munster of @ucsfcancer.bsky.social about her BRCA story and her mission to address the risk in carriers
podcasts.apple.com/us/podcast/t...
Early detection of cancer saves lives! We are getting better at this with new technology! In this weeks #Goodnewsaboutcancer we talk to Margaret Temepero of @ucsfcancer.bsky.social
podcasts.apple.com/us/podcast/t...
Hey @erictopol.bsky.social we agree! We started a podcast about all the progress against cancer!
podcasts.apple.com/us/podcast/t...
This weeks guest is Kimryn Rathmell, past Director of the National Cancer Institute (NCI) in a conversation about the wide reaching and critical role of this organization and it’s recent ‘24 in ‘24’ areas of progress! podcasts.apple.com/us/podcast/t...
This week we talk about the stunning 65% decrease in cervical cancer mortality in women under 25! The first generation of HPV vaccine recipients to reach adulthood.
Conversation with Ashish Deshmukh of MUSC
podcasts.apple.com/us/podcast/t...
Adrenal androgens and overall survival (OS) in men with castration-resistant prostate cancer (CRPC) treated with enzalutamide without (ENZ) or with abiraterone and prednisone (ENZ/AAP). #GU25
@charlesryanmd.bsky.social @mjmorrismd.bsky.social @ascopost.bsky.social meetings.asco.org/abstracts-pr...
Why is funding NIH so important? Listen to the Good News About Cancer w/ @charlesryanmd.bsky.social @mskcancercenter.bsky.social @drkarenknudsen.bsky.social & Dr. Morgans. Also amazing news about decline in lung cancer in Puerto Rico b/c of public health measures! podcasts.apple.com/us/podcast/4...
Thank you! What an honor it was to talk about the immense influence of this remarkable person.
Hey Bluesky friends- i’m happy to announce the launch of our new podcast – The Good News About Cancer! Did you know that there are 4.75 million Americans alive today whose lives have been saved by cancer that has been successfully treated or prevented? Lots more good news to come.
Just in time for Thanksgiving, nice pathology framework for characterizing treatment emergent neuroendocrine #ProstateCancer, a biologically diverse entity that everyone has a hard time describing, in CCR - thanks to Michael Haffner and @mishabeltran.bsky.social
aacrjournals.org/clincancerre...
I think of it as the ‘Schrodinger’s Cat’ stage of the disease. You don’t know if the cat ( the cancer ) is there or not unless you look- and if psa rises can reset the clock and determine when/if/how to restart
No strict policy per se but if PSA is <0.1 and 18-24 months has elapsed I am very open to discussing discontinuation. Only way to find out if we can cure in this space is to stop and check.
Important data @ccparker.bsky.social what are your thoughts on the duration of ADT and Abi in low volume mHSPC? Data free zone but lifelong ADT may need to be rethought?
Always wondered whether intermittent parpi use would reduce this likelihood as well as what ‘threshold’ is required before clinical progression. Could we act at first sign of RM’s? Lots of questions .
